229 related articles for article (PubMed ID: 21820239)
1. Re: Todd M. Morgan, Dominic Tang, Kelly L. Stratton, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 2011;59:923-8. Re: Umberto Capitanio, Francesco Montorsi. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues. Eur Urol 2011;59:929-30.
Brookman-May S; Burger M; Wieland WF; May M
Eur Urol; 2011 Nov; 60(5):e45-6; author reply e47. PubMed ID: 21820239
[No Abstract] [Full Text] [Related]
2. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues.
Capitanio U; Montorsi F
Eur Urol; 2011 Jun; 59(6):929-30. PubMed ID: 21444146
[No Abstract] [Full Text] [Related]
3. Reply to Umberto Capitanio, Paolo Dell'Oglio, Alessandro Larcher, and Francesco Montorsi's Reply to Kazutaka Saito's Words of Wisdom re: Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a-T1b Renal Mass and Normal Preoperative Renal Function. Eur Urol. 2016;69:538.
Saito K
Eur Urol; 2016 Oct; 70(4):e99. PubMed ID: 27197698
[No Abstract] [Full Text] [Related]
4. Re: Vincent Cloutier, Umberto Capitanio, Laurent Zini, et al. Thirty-day mortality after nephrectomy: clinical implications for informed consent. Eur urol 2009;56:998-1005.
Campodonico F; Capponi G; Maffezzini M
Eur Urol; 2009 Dec; 56(6):e45-6; author reply e47. PubMed ID: 19307052
[No Abstract] [Full Text] [Related]
5. Re: Robert J. Motzer, Pratik P. Rane, Todd L. Saretsky, et al. Patient-reported Outcome Measurement and Reporting for Patients with Advanced Renal Cell Carcinoma: A Systematic Literature Review. Eur Urol. Eur Urol. 2023;84:406-17.
Gutiérrez Rojas AF; Fernández D; Diaz Ritter C
Eur Urol; 2024 Mar; 85(3):e94. PubMed ID: 37802682
[No Abstract] [Full Text] [Related]
6. Re: Maxine Sun, Quoc-dien Trinh, Marco Bianchi, et al. A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol 2012;61:725-31.
Sandhu GS; Tanagho YS; Bhayani SB
Eur Urol; 2012 Sep; 62(3):e58; author reply e59-60. PubMed ID: 22704368
[No Abstract] [Full Text] [Related]
7. Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017;71:606-17.
Marconi L; MacLennan S; Lam TBL; Canfield SE; Yuan Y; Omar MI; N'Dow J; Sylvester R
Eur Urol; 2017 Sep; 72(3):e59-e60. PubMed ID: 28629586
[No Abstract] [Full Text] [Related]
8. Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
Kim JH; Chung BI
Eur Urol; 2017 Nov; 72(5):e127-e128. PubMed ID: 28545840
[No Abstract] [Full Text] [Related]
9. Re: Hendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al. A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52.
Sun M; Hansen J; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):e37-8. PubMed ID: 22172372
[No Abstract] [Full Text] [Related]
10. Re: Hendrik van Poppel, Luigi da Pozzo, Walter Albrecht, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52.
Ganesamoni R; Mavuduru R; Agarwal MM
Eur Urol; 2011 Aug; 60(2):e9; author reply e10. PubMed ID: 21621322
[No Abstract] [Full Text] [Related]
11. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
Mouracade P
Eur Urol; 2015 Oct; 68(4):e82-3. PubMed ID: 26033152
[No Abstract] [Full Text] [Related]
12. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
Potretzke AM; Larson JA; Bhayani SB
Eur Urol; 2015 Feb; 67(2):e19-20. PubMed ID: 25269382
[No Abstract] [Full Text] [Related]
13. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
Zargar H; Coelho RF; Kaouk JH
Eur Urol; 2015 Feb; 67(2):e23. PubMed ID: 25266972
[No Abstract] [Full Text] [Related]
14. Re: Hiury S. Andrade, Homayoun Zargar, Peter A. Caputo, et al. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma. Eur Urol 2016;69:1149-54.
Shin TY; Abdel Raheem A; Rha KH
Eur Urol; 2016 Oct; 70(4):e100-e101. PubMed ID: 26995331
[No Abstract] [Full Text] [Related]
15. Re: Günter Janetschek. Laparoscopic partial nephrectomy for RCC: how can we avoid ischemic damage of the renal parenchyma? Eur Urol 2007;52:1303-5.
Simone G; Guaglianone S; Gallucci M
Eur Urol; 2008 Jun; 53(6):1302-3; author reply 1303-4. PubMed ID: 18222605
[No Abstract] [Full Text] [Related]
16. Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):e21-2. PubMed ID: 25257031
[No Abstract] [Full Text] [Related]
17. Re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting Functional Outcomes After Partial and Radical Nephrectomy. Eur Urol 2019;75:766-72: Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
Takahashi T
Eur Urol; 2019 Sep; 76(3):e65-e66. PubMed ID: 31164251
[No Abstract] [Full Text] [Related]
18. Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Oct; 68(4):e84-5. PubMed ID: 26058957
[No Abstract] [Full Text] [Related]
19. Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3-5.
Capitanio U; Bedke J; Albiges L; Volpe A; Giles RH; Hora M; Marconi L; Klatte T; Abu-Ghanem Y; Dabestani S; Fernández Pello S; Hofmann F; Kuusk T; Campi R; Tahbaz R; Powles T; Ljungberg B; Bex A
Eur Urol; 2023 Mar; 83(3):e74-e75. PubMed ID: 36526491
[No Abstract] [Full Text] [Related]
20. Re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
Kim WH; Yoon HK; Jeong CW
Eur Urol; 2020 Jan; 77(1):e14-e15. PubMed ID: 31586511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
